03:19 AM EDT, 06/25/2025 (MT Newswires) -- Forte Biosciences ( FBRX ) said Wednesday it priced a public offering of about 5.6 million shares at $12 apiece, and in lieu of stock to certain investors, pre-funded warrants to buy up to 619,606 shares at $11.999 per warrant.

The company granted underwriters a 30-day option to purchase up to an additional 937,508 shares.

Forte Biosciences ( FBRX ) expects to raise about $75 million in gross proceeds from the offering, which is anticipated to close on or about Thursday.

The company aims to use the proceeds for general corporate purposes and working capital.